Literature DB >> 21615260

Zebrafish behavioural assays of translational relevance for the study of psychiatric disease.

Caroline H Brennan1.   

Abstract

Understanding the pathogenesis of the complex behavioural disorders that constitute psychiatric disease is a major challenge for biomedical research. Assays in rodents have contributed significantly to our understanding of the neural basis of behavioural disorders and continue to be one of the main focuses for the development of novel therapeutics. Now, owing to their genetic tractability and optical transparency (allowing in vivo imaging of circuit function) and the rapid expansion of genetic tools, zebrafish are becoming increasingly popular for behavioural genetic research. The increased development of behavioural assays in zebrafish raises the possibility of exploiting the advantages of this system to identify molecular mechanisms contributing to behavioural phenotypes associated with psychiatric disorders as well as potential therapeutics. This mini-review describes behavioural paradigms in zebrafish that can be used to address endophenotypes associated with psychiatric disease. The content reflects the interests of the author and covers tests of cognitive functions, response choice and inhibition, social interaction and executive function.

Entities:  

Mesh:

Year:  2011        PMID: 21615260     DOI: 10.1515/RNS.2011.006

Source DB:  PubMed          Journal:  Rev Neurosci        ISSN: 0334-1763            Impact factor:   4.353


  21 in total

1.  Development and implementation of a three-choice serial reaction time task for zebrafish (Danio rerio).

Authors:  Matthew O Parker; Mollie E Millington; Fraser J Combe; Caroline H Brennan
Journal:  Behav Brain Res       Date:  2011-10-31       Impact factor: 3.332

2.  EuFishBioMed (COST Action BM0804): a European network to promote the use of small fishes in biomedical research.

Authors:  Uwe Strähle; Laure Bally-Cuif; Robert Kelsh; Dimitris Beis; Marina Mione; Pertti Panula; Antonio Figueras; Yoav Gothilf; Christian Brösamle; Robert Geisler; Gudrun Knedlitschek
Journal:  Zebrafish       Date:  2012-04-26       Impact factor: 1.985

3.  Imaging escape and avoidance behavior in zebrafish larvae.

Authors:  Ruth M Colwill; Robbert Creton
Journal:  Rev Neurosci       Date:  2011       Impact factor: 4.353

Review 4.  Zebrafish as an emerging model for studying complex brain disorders.

Authors:  Allan V Kalueff; Adam Michael Stewart; Robert Gerlai
Journal:  Trends Pharmacol Sci       Date:  2014-01-09       Impact factor: 14.819

Review 5.  Zebrafish models in neuropsychopharmacology and CNS drug discovery.

Authors:  Kanza M Khan; Adam D Collier; Darya A Meshalkina; Elana V Kysil; Sergey L Khatsko; Tatyana Kolesnikova; Yury Yu Morzherin; Jason E Warnick; Allan V Kalueff; David J Echevarria
Journal:  Br J Pharmacol       Date:  2017-04-05       Impact factor: 8.739

6.  Behavioral performance altering effects of MK-801 in zebrafish (Danio rerio).

Authors:  Margarette Sison; Robert Gerlai
Journal:  Behav Brain Res       Date:  2011-02-17       Impact factor: 3.332

7.  Hooked! Modeling human disease in zebrafish.

Authors:  Cristina Santoriello; Leonard I Zon
Journal:  J Clin Invest       Date:  2012-07-02       Impact factor: 14.808

Review 8.  Zebrafish models for translational neuroscience research: from tank to bedside.

Authors:  Adam Michael Stewart; Oliver Braubach; Jan Spitsbergen; Robert Gerlai; Allan V Kalueff
Journal:  Trends Neurosci       Date:  2014-04-09       Impact factor: 13.837

9.  Maturation of shoaling in two zebrafish strains: a behavioral and neurochemical analysis.

Authors:  Samantha Mahabir; Diptendu Chatterjee; Christine Buske; Robert Gerlai
Journal:  Behav Brain Res       Date:  2013-03-18       Impact factor: 3.332

10.  Production of bioactive recombinant human fibroblast growth factor 12 using a new transient expression vector in E. coli and its neuroprotective effects.

Authors:  Mi Zhou; Jiangfei Chen; Kuikui Meng; Yu Zhang; Meng Zhang; Panyu Lu; Yongjun Feng; Mai Huang; Qiaoxiang Dong; Xiaokun Li; Haishan Tian
Journal:  Appl Microbiol Biotechnol       Date:  2021-07-10       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.